Colon Cancer Basic Science 9/21/05. Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths.

Slides:



Advertisements
Similar presentations
Surveillance/ Screening Colonoscopy for Colorectal Cancer
Advertisements

Diagnosis.
Polyps – Where do they come from and what do you do with them?!
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Prof. Faisal Ghani Siddiqui FCPS; PGDip-bioethics; MCPS-HPE
COLORECTAL BLEEDING: A MULTIDISCIPLINARY APPROACH PATIENTS EVALUATION AND DIAGNOSIS: COLONSCOPY Stefania Caronna MD Dept. of Gastroenterology Molinette.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
COLORECTAL CARCINOMA Bernard M. Jaffe, MD Professor of Surgery Emeritus.
Colorectal Cancer Ramon Garza III, M.D.. Colorectal CA DNA Sequencing Mismatch Repair Genes Genomics Role of PCR and FISH in Colon CA.
NSABP PROTOCOL C-10: RESULTS A Phase II Trial of 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) Plus Bevacizumab for Patients with Unresectable.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Colorectal Cancer (CRC)
Colon Cancer Colon Cancer By: Ryan Feldt What is Colon Cancer? What is Colon Cancer? n A disease in which cancer cells are found in the tissue of the.
Tumors of the bile ducts
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
Colon Cancer by Bryan E. Mosora, D.O..
Colorectal cancer Khayal AlKhayal MD,FRCSC
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
General Medicine Subspecialty Conference Colon Cancer Screening General Medicine Subspecialty Conference Colon Cancer Screening Selim Krim, MD Assistant.
Understanding Lower Bowel Disease
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Colorectal carcinoma Dr.Mohammadzadeh.
Colon Cancer First Page.
Colorectal cancer Khayal AlKhayal MD,FRCSC Assistant professor of Surgery Consultant Colorectal surgeon 9/11/2015Shwartz.
Resection For Lung Metastases M62 Coloproctology Course.
In the name of God Isfahan medical school Shahnaz Aram MD.
Interventions for Clients with Colorectal Cancer
Common small and large intestinal surgical diseases Part II
PANCREATIC CANCER.
T4 Colon Cancer and Laparoscopic Approach Gustavo Plasencia MD FACS, FASCRS Clinical Professor of Surgery Gustavo Plasencia MD FACS, FASCRS Clinical Professor.
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
Colorectal Cancer. Colorectal cancer - statistics Leading causes of cancer death in the US Male Female Lung – 31% Lung – 25% Prostate – 11% Breast – 11%
COLORECTAL CANCER Ozlem Uysal-Sonmez, MD Yeditepe University Hospital Department of Medical Oncology.
Cancer colon.
Change in bowel habits … 60 year old male Complains of progressive constipation for the past 6 months.
Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment.
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
Pathology Report Colorectal Cancer Sahar Najibi April 11 th, 2008.
A 58 years old man presents with melena. What would you ask him?
Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4.
Pancreatic cancer.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of colorectal cancer: case report and literature review Alexandra.
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
Synchronous Metastasis on Staging/Surveillance CT chest abdomen & Pelvis + CEA + MRI Liver /PET-CT Synchronous Metastasis on Staging/Surveillance CT chest.
Definition Signs & symptoms Treatment Root of the disease.
Interventions for Clients with Colorectal Cancer.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Role of MRI in Primary Rectal Cancer Staging and Management
Laparoscopic vs. Conventional Resections for Colorectal Carcinoma 2LT Pil (Pete) Kang New York University School of Medicine 28 September 2000.
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Colon Cancer. What is Colon Cancer?  Cancer that begins in the colon or rectum  The colon and rectum are both parts of the large intestine  The third.
Case. Kreem is 53 year old man who is quite healthy with no previous illness. He has noticed changes in his bowel habits for the last few months, with.
POLYPS CHOLORECTAL CANCER M. DuBois Fennal, PhD, RN, CNS.
Adenocarcinoma Colon in children Dr.Raad S. AL-Saffar C.A.B.S.
Karcinom rektuma- management
Cancer colon.
Dr.Amit Gupta Associate Professor Dept. of Surgery
Module 4: Colorectal Cancer
A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.
Polyps of the Colon and Rectum
Neoadjuvant Adjuvant Curative Palliative
Nursing care of patients operated-on for CRC
Changes in TNM 8 To be used from
Presentation transcript:

Colon Cancer Basic Science 9/21/05

Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths in both genders in the US. The lifetime risk of developing colorectal cancer in this country is 10%. Over 90% of cases occur after the age of 50. Colorectal cancer occurs in 3 forms: sporadic, hereditary and familial. In the sporadic form, there is typically an absence of family history, it tends to affect the older population, and although the specific mutation is present in all cells, only colon or rectal cells are affected.

Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths in both genders in the US. T The lifetime risk of developing colorectal cancer in this country is 10%. F, 6% Over 90% of cases occur after the age of 50. T Colorectal cancer occurs in 3 forms: sporadic, hereditary and familial. T In the sporadic form, there is typically an absence of family history, it tends to affect the older population, and although the specific mutation is present in all cells, only colon or rectal cells are affected. F, genetic mutations associated with the cancer are limited to the tumor itself.

All the following concerning cancers in the left colon are true except: Are often obstructive on presentation. Can present as LLQ pain, fever, and obstructive symptoms mimicking diverticulitis. If bleeding is present, is more likely to present as bright red blood per rectum. Represent a majority (>80%) of all colon cancers.

All the following concerning cancers in the left colon are true except: Are often obstructive on presentation. T Can present as LLQ pain, fever, and obstructive symptoms mimicking diverticulitis. T If bleeding is present, is more likely to present as bright red blood per rectum. T, although a majority of colon cancers present as occult. Represent a majority (>80%) of all colon cancers. F, at least half of all colon cancers are located proximal to the area visualized by a flex sigmoidoscopy, and the incidence of right colon cancers is rising.

All the following concerning the surgical approach to colon cancer are true except: Ileocolic anastamosis after colon resection for cancer is generally avoided in patients presenting with complete obstruction. Non-obstructing patients should undergo metastatic w/u including PE, CXR, LFT’s, CEA, and abdominal CT. The presence of hepatic metastases generally precludes colonic resection of the tumor. The proximal sigmoid is often excluded from an anastamosis due to poor blood supply and frequent involvement with diverticular disease.

All the following concerning the surgical approach to colon cancer are true except: Ileocolic anastomosis after colon resection for cancer is generally avoided in patients presenting with complete obstruction. T due to high risk of leak. Non-obstructing patients should undergo metastatic w/u including PE, CXR, LFT’s, CEA, and abdominal CT. T The presence of hepatic metastases generally precludes colonic resection of the tumor. F, excision of the primary cancer can provide significant palliation. The proximal sigmoid is often excluded from an anastomosis due to poor blood supply and frequent involvement with diverticular disease. T

Which of the following concerning colorectal cancer staging are correct? Stage 1 consists of tumors invading the submucosa (T1) or muscularis (T2) without nodal disease (N0). Lymph node metastases automatically classifies a lesion as stage 4. 5 year survival for stage 1 and 2 cancers is as high as 75% and 50% respectively with appropriate resection. All stages of cancer benefit from adjuvant chemotherapy such as 5-FU and Leukovorin after curative resection.

Which of the following concerning colorectal cancer staging are correct? Stage 1 consists of tumors invading the submucosa (T1) or muscularis (T2) without nodal disease (N0).T Lymph node metastases automatically classifies a lesion as stage 4. F, Stages 3 and 4 both include nodal metastases with 4 having distant metastases. 5 year survival for stage 1 and 2 cancers is as high as 75% and 50% respectively with appropriate resection. F, 90% and 75% respectively, which are improved with adjuvant chemotherapy. All stages of cancer benefit from adjuvant chemotherapy such as 5-FU and Leukovorin after curative resection. F, stage 3 clearly benefits with stages 1 and 2 showing no clear benefit.(controversial)

Local excision is considered appropriate therapy for rectal CA under which of the following conditions? Applies to small cancers of the distal rectum that have not penetrated the muscularis. The tumor is mobile and less than 10cm in diameter. Less than 40% of the rectal wall circumference may be involved. Lesions must be within 2cm of the anal verge. Lesions are classified as stage 1 or 2. Is appropriate for palliation in patients with advanced cancer and severe co-morbid disease. Adequate clear margins are attainable.

Local excision is considered appropriate therapy for rectal CA under which of the following conditions? Applies to small cancers of the distal rectum that have not penetrated the muscularis. T The tumor is mobile and less than 10cm in diameter. F, mobile and less than 4cm. Less than 40% of the rectal wall circumference may be involved. T Lesions must be within 2cm of the anal verge. F, must be within 6cm of anal verge. Lesions are classified as stage 1 or 2. F, applicable to Stage 1 (T1 and T2) only. Is appropriate for palliation in patients with advanced cancer and severe co-morbid disease. T Adequate clear margins are attainable. T

The use of fulguration in rectal lesions is significantly limited by: Destroys the tumor by creating an eschar that extends into perirectal fat and thus destroys the tumor and rectal wall. Can only be used for lesions located below the peritoneal reflection. Can be complicated by significant postoperative fevers and bleeding up to 10days out. By virtue of its mechanism of action cannot produce a specimen for pathologic evaluation. Is used in patients with prohibitive operative risk or those with limited life expectancy.

The use of fulguration in rectal lesions is significantly limited by: Destroys the tumor by creating an eschar that extends into perirectal fat and thus destroys the tumor and rectal wall. T Can only be used for lesions located below the peritoneal reflection. T Can be complicated by significant postoperative fevers and bleeding up to 10 days out. T By virtue of its mechanism of action cannot produce a specimen for pathologic evaluation. T Is used in patients with prohibitive operative risk or those with limited life expectancy. T